BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25981026)

  • 1. Is the current model for acne pathogenesis backwards?
    Metiko B; Brooks K; Burkhart CG; Burkhart CN; Morrell D
    J Am Acad Dermatol; 2015 Jun; 72(6):e167. PubMed ID: 25981026
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of Propionibacterium acnes associated biofilm formation by Decanediol.
    Sulzberger M; Fölster H; Sattler M; Rippke F; Grönniger E
    J Dermatol Sci; 2016 Aug; 83(2):159-61. PubMed ID: 27188522
    [No Abstract]   [Full Text] [Related]  

  • 3. Treating acne with antibiotic-resistant bacterial colonization.
    Tzellos T; Zampeli V; Makrantonaki E; Zouboulis CC
    Expert Opin Pharmacother; 2011 Jun; 12(8):1233-47. PubMed ID: 21355786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the microcomedone theory and acne therapeutics: Propionibacterium acnes biofilm produces biological glue that holds corneocytes together to form plug.
    Burkhart CG; Burkhart CN
    J Am Acad Dermatol; 2007 Oct; 57(4):722-4. PubMed ID: 17870436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propionibacterium acnes and antimicrobial resistance in acne.
    Dessinioti C; Katsambas A
    Clin Dermatol; 2017; 35(2):163-167. PubMed ID: 28274353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do we really need topical antibiotics in our new treatment paradigm of acne vulgaris? A novel question to consider based on an updated model of pathogenesis.
    Kircik LH
    J Drugs Dermatol; 2013 Aug; 12(8 Suppl):s107. PubMed ID: 23986174
    [No Abstract]   [Full Text] [Related]  

  • 7. Looking back to the future--acne.
    Cunliffe WJ
    Dermatology; 2002; 204(3):167-72. PubMed ID: 12037442
    [No Abstract]   [Full Text] [Related]  

  • 8. Current concepts in therapy: the treatment of acne with antibiotics.
    South Med J; 1973 Apr; 66(4):494-6. PubMed ID: 4267707
    [No Abstract]   [Full Text] [Related]  

  • 9. Acne and Propionibacterium acnes.
    Bojar RA; Holland KT
    Clin Dermatol; 2004; 22(5):375-9. PubMed ID: 15556721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propionibacterial biofilms cannot explain antibiotic resistance but might contribute to some cases of antibiotic recalcitrant acne.
    Coates T; Eady A; Cove J
    Br J Dermatol; 2003 Feb; 148(2):366-7. PubMed ID: 12588400
    [No Abstract]   [Full Text] [Related]  

  • 11. Acne vulgaris: new evidence in pathogenesis and future modalities of treatment.
    Hazarika N
    J Dermatolog Treat; 2021 May; 32(3):277-285. PubMed ID: 31393195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of macrolide therapy on patients with acne vulgaris].
    Akamatsu H
    Jpn J Antibiot; 2001 Feb; 54 Suppl A():109-12. PubMed ID: 11439886
    [No Abstract]   [Full Text] [Related]  

  • 13. Sampling and detection of skin Propionibacterium acnes: current status.
    Alexeyev OA; Jahns AC
    Anaerobe; 2012 Oct; 18(5):479-83. PubMed ID: 22877737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of acne vulgaris: recent advances.
    Bhambri S; Del Rosso JQ; Bhambri A
    J Drugs Dermatol; 2009 Jul; 8(7):615-8. PubMed ID: 19588637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro resistance of Propionibacterium acnes and Staphylococcus epidermidis to antibiotics: should our antibiotic prescription practices for the treatment of acne be changed?].
    Bourgault-Villada I
    Ann Dermatol Venereol; 1998 Dec; 125(12):879-80. PubMed ID: 9922858
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapy for acne vulgaris.
    Leyden JJ
    N Engl J Med; 1997 Apr; 336(16):1156-62. PubMed ID: 9099661
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris.
    Kurokawa I; Nishijima S; Kawabata S
    Eur J Dermatol; 1999; 9(1):25-8. PubMed ID: 9920982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acne: evolving concepts of pathogenesis need to guide therapeutic developments.
    Weiss JS
    J Drugs Dermatol; 2013 Jun; 12(6):s66. PubMed ID: 23839202
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimicrobial susceptibility of Propionibacterium acnes isolates from acne patients in Colombia.
    Mendoza N; Hernandez PO; Tyring SK; Haitz KA; Motta A
    Int J Dermatol; 2013 Jun; 52(6):688-92. PubMed ID: 23451873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
    Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H
    Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.